News
Feng's remark on the city of Tianjin echoes the essence of the "Shanghai Spirit" with all its vitality, a spirit marked by ...
Global ophthalmologists and industry experts have called for innovation and advancement of global ophthalmic technology, as ...
2d
Daily Times(PK) on MSNPakistan, Russia eye freight train launch in AugustA top Russian official on Thursday described Pakistan as an “important partner” in the region’s economic and energy ...
Prothrombin Complex Concentrate Market to Grow at a CAGR of 9.6%, Reaching nearly USD 4.8 Bn by 2032
SAN FRANCISCO, CA, UNITED STATES, July 7, 2025 /EINPresswire.com/ -- Stellar Market Research examines the growth rate of the Prothrombin Complex Concentrate Market during the forecasted period ...
2d
RUN | Powered by Outside on MSN12 Run Races You Can Turn into a VacationLooking for your next race and getaway in one? Discover 12 scenic run events perfect for combining a fitness goal with a ...
Photo taken on Oct 5, 2022 shows the giant Ferris wheel called the "Tianjin Eye" in North China's Tianjin. The wheel is 110 meters in diameter and equipped with 48 capsules. [Photo/VCG] TIANJIN - A 12 ...
Looking for information on Tianjin Binhai International Airport, Tianjin, China? Know about Tianjin Binhai International Airport in detail. Find out the location of Tianjin Binhai International ...
Company profile for Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd. A including key executives, insider trading, ownership, revenue and average growth rates. View detailed 600329.CN ...
Fetfatzidis was labelled the "Greek Messi" in 2010 as he continued to impress for Olympiacos. He was praised by Bleacher Report for his superb ball control and "excellent eye for goal" but ultimately, ...
AstraZeneca spinout Dizal Pharmaceuticals won an FDA accelerated approval for sunvozertinib for previously treated EGFR ex 20-mutated non-small cell lung cancer. To be marketed as Zegfrovy, the oral ...
Spain's SpliceBio has raised $135m in financing that will help it move a gene-editing therapy for Stargardt disease through clinical testing.
Eisai and Biogen have completed their rolling biologics license application in the US for a subcutaneous formulation of Alzheimer's disease therapy Leqembi previously delayed by the FDA on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results